StockClub

News

Aug 11 (Tue)
EarningsRestaurant Brands International Inc.QSRSeeking Alpha

Restaurant Brands International: Burger King Is Turning Up The Heat

Restaurant Brands International is upgraded to a buy as Burger King's turnaround drives market share gains over McDonald's. QSR's valuation has improved, with a TTM PE of 18.5 and low FCF growth requi

OtherIntel Corp.INTCSeeking Alpha

Intel Joins Race To Sell Shares At Sky-High Prices After Spike - Big Tech Figured It Out, The Economy Benefits, Maybe Not Investors

Vast amounts of cash get moved from Investors to Big Tech via equity and debt sales to be spent in the real economy. Intel announced on Monday that it plans an offering of $15 billion in common stock.

EarningsFiscalNote Holdings, Inc.NOTESeeking Alpha

FiscalNote Holdings, Inc. (NOTE) Q2 2026 Earnings Call Prepared Remarks Transcript

FiscalNote Holdings, Inc. (NOTE) Q2 2026 Earnings Call Prepared Remarks Transcript

EarningsRADCOM Ltd.RDCMSeeking Alpha

Radcom: Guidance Was Cut, But I'm Still Bullish

RADCOM Ltd. faces a significant revenue guidance cut for 2026, now expecting $57–$63 million, down from the prior $78.6 million midpoint. Despite the setback, RDCM's valuation at $10 per share and $60

M&AApple Inc.AAPLBenzinga

Archer Aviation Exec Says Boeing Deal Will ‘Significantly Change the Profile' as $200 Million Insitu Business Joins Portfolio

Archer Aviation Inc.‘s (NYSE:ACHR) deal with Boeing Co. (NYSE:BA) could significantly reshape the electric vertical take-off and landing (eVTOL) company.

Archer Aviation Inc.ACHRSeeking Alpha

Archer Aviation Inc. (ACHR) Q2 2026 Earnings Call Transcript

Archer Aviation Inc. (ACHR) Q2 2026 Earnings Call Transcript

EarningsCardinal Health, Inc.CAHBenzinga

Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Cardinal Health, Inc. (NYSE:CAH) will release its fourth quarter earnings report before the opening bell on Tuesday, Aug. 11.

Sponsored
OtherTenax Therapeutics, Inc.TENXMarketBeat

Tenax LEVEL Trial Misses Primary Goal, but Subgroup Data Bolsters Levosimendan Case

Tenax Therapeutics NASDAQ: TENX reported that its Phase III LEVEL trial of oral levosimendan in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction, or

OtherMNONewsfile Corp

Meridian Drills Multiple, Stacked Layers of Gold-Copper-Silver and Zinc-Lead VMS Mineralisation Below Santa Helena

Highlights: Lower zone of multiple stacked layers of Au-Cu-Ag & Zn-Pb VMS mineralisation drilled at Santa Helena; — CD-878's upper layer drills 11.3m @ 0.8g/t Au, 0.2% Cu, 17.6g/t Ag, 3.4% Zn & 0.6%

EarningsHims & Hers Health, Inc.HIMSSeeking Alpha

Hims & Hers Health, Inc. (HIMS) Q2 2026 Earnings Call Transcript

Hims & Hers Health, Inc. (HIMS) Q2 2026 Earnings Call Transcript

Insight Molecular Diagnostics Inc.IMDXSeeking Alpha

Insight Molecular Diagnostics Inc. (IMDX) Q2 2026 Earnings Call Transcript

Insight Molecular Diagnostics Inc. (IMDX) Q2 2026 Earnings Call Transcript

GUDDYGUDDYSeeking Alpha

Amotiv Limited (GUDDY) Q4 2026 Earnings Call Transcript

Amotiv Limited (GUDDY) Q4 2026 Earnings Call Transcript

SUNCSUNCSeeking Alpha

SunocoCorp: Parkland Synergies And Cash Flow Growth Drive Upside

Sunoco LP has transformed into a diversified multinational platform, integrating fuel distribution, pipelines, terminals, convenience stores, and refining assets. Q2 2026 results showed net income of

EarningsExodus Movement, Inc.EXODSeeking Alpha

Exodus Movement, Inc. (EXOD) Q2 2026 Earnings Call Transcript

Exodus Movement, Inc. (EXOD) Q2 2026 Earnings Call Transcript

Sponsored
EarningsPampa Energía S.A.PAMSeeking Alpha

Pampa Energia: Rincon De Aranda And Fertilizers Add New Legs To The Bull Case

Pampa Energia's Q2 results reinforced the long-term bullish thesis, with adjusted EBITDA up 75% Y/Y to $415M as Rincón de Aranda and power generation drove performance. Rincón de Aranda is scaling rap

OtherSilence Therapeutics plcSLNMarketBeat

Silence Therapeutics' Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial

Silence Therapeutics NASDAQ: SLN reported top-line results from its Phase II SANRECO trial of divesiran in patients with phlebotomy-dependent polycythemia vera, or PV, with the study meeting its prima

MacroUnited States Brent Oil Fund LPBNOCNBC

Hormuz Deadlock: Where oil prices could head next as prospects for an imminent deal fade

Oil price gains remained in check on Monday, even after Washington's latest hints of an imminent U.S.-Iran deal to reopen the Strait of Hormuz failed to deliver. Market moves won't be so "benign" if t

OtherFox Business

Wealthy Americans look to New Zealand as demand for 'golden visas' booms

New Zealand golden visa applications surged with over 700 wealthy foreigners applying in 14 months. Americans filed over one-third of applications since April 2025.

Fox Business

Nearly 30,000 pounds of raw beef recalled over missed import inspection

Nearly 30,000 pounds of imported Argentina beef were recalled in Florida and Texas by Corte Argentino USA LLC after missing reinspection.

SoftBank Corp.SFBQFCNBC

U.S. judge ends graft case against Indian billionaire Gautam Adani

A U.S. judge dismissed the bribery case against Indian billionaire Gautam Adani, ending the businessman's legal woes in the U.S. However, the judge said "irregularities" in the DOJ's move to dismiss t